Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
| Total | Transactions | Amount |
| Buys | 0 | $0 |
| Sells | 11 | $879,920 |
| Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
| 18 Jan 2024 16:38 | MRTX | Mirati Therapeutics Inc | CHRISTENSEN JAMIE | EVP & Chief Scientific Officer | 16 Jan 2024 | Sale | 631 | 59.02 | 37,242 | D |
| 18 Jan 2024 16:38 | MRTX | Mirati Therapeutics Inc | CHRISTENSEN JAMIE | EVP & Chief Scientific Officer | 16 Jan 2024 | Sale | 966 | 59.02 | 57,013 | D |
| 05 Jan 2024 17:34 | MRTX | Mirati Therapeutics Inc | CHRISTENSEN JAMIE | EVP & Chief Scientific Officer | 04 Jan 2024 | Sale | 1,531 | 58.81 | 90,038 | D |
| 19 Dec 2023 16:59 | MRTX | Mirati Therapeutics Inc | CHRISTENSEN JAMIE | EVP & Chief Scientific Officer | 18 Dec 2023 | Sale | 2,387 | 57.5 | 137,252 | D |
| 12 Sep 2023 17:41 | MRTX | Mirati Therapeutics Inc | CHRISTENSEN JAMIE | EVP & Chief Scientific Officer | 08 Sep 2023 | Sale | 2,388 | 35.63 | 85,084 | D |
| 24 May 2023 19:38 | MRTX | Mirati Therapeutics Inc | CHRISTENSEN JAMIE | EVP & Chief Scientific Officer | 24 May 2023 | Sale | 619 | 45.2905 | 28,035 | D |
| 19 Jan 2023 09:45 | MRTX | Mirati Therapeutics Inc | CHRISTENSEN JAMIE | EVP, Chief Scientific Officer | 17 Jan 2023 | Sale | 887 | 42.3821 | 37,593 | D |
| 19 Jan 2023 09:45 | MRTX | Mirati Therapeutics Inc | CHRISTENSEN JAMIE | EVP, Chief Scientific Officer | 17 Jan 2023 | Sale | 1,358 | 42.3778 | 57,549 | D |
| 05 Jan 2023 17:13 | MRTX | Mirati Therapeutics Inc | CHRISTENSEN JAMIE | EVP, Chief Scientific Officer | 04 Jan 2023 | Sale | 1,949 | 46.6 | 90,823 | D |
| 20 Dec 2022 16:02 | MRTX | Mirati Therapeutics Inc | CHRISTENSEN JAMIE | EVP, Chief Scientific Officer | 16 Dec 2022 | Sale | 2,410 | 42.9977 | 103,624 | D |
| 05 Dec 2022 17:00 | MRTX | Mirati Therapeutics Inc | CHRISTENSEN JAMIE | EVP, Chief Scientific Officer | 02 Dec 2022 | Sale | 1,726 | 90.1893 | 155,667 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)